Evasion of neutrophil killing by Staphylococcus aureus

Pathogens

Volumn 5, Issue 1, 2016, Pages

  McGuinness, Will A ^a   Kobayashi, Scott D ^a   DeLeo, Frank R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Innate immunity; Neutrophil; Phagocytosis; PMN; Staphylococcus aureus

Indexed keywords

HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INNATE IMMUNITY; NECROSIS; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PYROPTOSIS; REVIEW; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

EID: 84983477729     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens5010032     Document Type: Review

References (98)

1. Diekema, D.J.; Pfaller, M.A.; Schmitz, F.J.; Smayevsky, J.; Bell, J.; Jones, R.N.; Beach, M.; Group, S.P. Survey of infections due to staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the united states, canada, latin america, europe, and the western pacific region for the sentry antimicrobial surveillance program, 1997-1999. Clin. Infect. Dis. 2001, 32 (Suppl. 2), S114-S132. [PubMed]
2. Gorwitz, R.J.; Kruszon-Moran, D.; McAllister, S.K.; McQuillan, G.; McDougal, L.K.; Fosheim, G.E.; Jensen, B.J.; Killgore, G.; Tenover, F.C.; Kuehnert, M.J. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the united states, 2001-2004. J. Infect. Dis. 2008, 197, 1226-1234. [CrossRef] [PubMed]
3. DeLeo, F.R.; Otto, M.; Kreiswirth, B.N.; Chambers, H.F. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010, 375, 1557-1568. [CrossRef]
4. Talan, D.A.; Krishnadasan, A.; Gorwitz, R.J.; Fosheim, G.E.; Limbago, B.; Albrecht, V.; Moran, G.J.; Group, E.M.I.N.S. Comparison of Staphylococcus aureus from skin and soft-tissue infections in us emergency department patients, 2004 and 2008. Clin. Infect. Dis. 2011, 53, 144-149. [CrossRef] [PubMed]
5. Klevens, R.M.; Morrison, M.A.; Nadle, J.; Petit, S.; Gershman, K.; Ray, S.; Harrison, L.H.; Lynfield, R.; Dumyati, G.; Townes, J.M. et al. Invasive methicillin-resistant Staphylococcus aureus infections in the united states. JAMA 2007, 298, 1763-1771. [CrossRef] [PubMed]
6. Fridkin, S.K.; Hageman, J.C.; Morrison, M.; Sanza, L.T.; Como-Sabetti, K.; Jernigan, J.A.; Harriman, K.; Harrison, L.H.; Lynfield, R.; Farley, M.M. et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl. J. Med. 2005, 352, 1436-1444. [CrossRef] [PubMed]
7. Chambers, H.F.; Deleo, F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 2009, 7, 629-641. [CrossRef] [PubMed]
8. DeLeo, F.R.; Chambers, H.F. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J. Clin. Investig. 2009, 119, 2464-2474. [CrossRef] [PubMed]
9. Lekstrom-Himes, J.A.; Gallin, J.I. Immunodeficiency diseases caused by defects in phagocytes. N. Engl. J. Med. 2000, 343, 1703-1714. [PubMed]
10. Rankin, S.M. The bone marrow: A site of neutrophil clearance. J. Leukoc. Biol. 2010, 88, 241-251. [CrossRef] [PubMed]
11. Summers, C.; Rankin, S.M.; Condliffe, A.M.; Singh, N.; Peters, A.M.; Chilvers, E.R. Neutrophil kinetics in health and disease. Trends. Immunol. 2010, 31, 318-324. [CrossRef] [PubMed]
12. Phillipson, M.; Kubes, P. The neutrophil in vascular inflammation. Nat. Med. 2011, 17, 1381-1390. [CrossRef] [PubMed]
13. Ley, K.; Laudanna, C.; Cybulsky, M.I.; Nourshargh, S. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7, 678-689. [CrossRef] [PubMed]
14. Sadik, C.D.; Kim, N.D.; Luster, A.D. Neutrophils cascading their way to inflammation. Trends Immunol. 2011, 32, 452-460. [CrossRef] [PubMed]
15. Gillrie, M.R.; Zbytnuik, L.; McAvoy, E.; Kapadia, R.; Lee, K.; Waterhouse, C.C.; Davis, S.P.; Muruve, D.A.; Kubes, P.; Ho, M. Divergent roles of toll-like receptor 2 in response to lipoteichoic acid and Staphylococcus aureus in vivo. Eur. J. Immunol. 2010, 40, 1639-1650. [CrossRef] [PubMed]
16. Von Aulock, S.; Morath, S.; Hareng, L.; Knapp, S.; Van Kessel, K.P.; Van Strijp, J.A.; Hartung, T. Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment. Immunobiology 2003, 208, 413-422. [CrossRef] [PubMed]
17. Leemans, J.C.; Heikens, M.; van Kessel, K.P.; Florquin, S.; van der Poll, T. Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice. Clin. Diagn. Lab. Immunol. 2003, 10, 950-953. [CrossRef] [PubMed]
18. Lotz, S.; Aga, E.; Wilde, I.; van Zandbergen, G.; Hartung, T.; Solbach, W.; Laskay, T. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via cd14 and tlr2. J. Leukoc. Biol. 2004, 75, 467-477. [CrossRef] [PubMed]
19. Mullaly, S.C.; Kubes, P. The role of tlr2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. J. Immunol. 2006, 177, 8154-8163. [CrossRef] [PubMed]
20. Hoogerwerf, J.J.; de Vos, A.F.; Bresser, P.; van der Zee, J.S.; Pater, J.M.; de Boer, A.; Tanck, M.; Lundell, D.L.; Her-Jenh, C.; Draing, C. et al. Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans. Am. J. Respir. Crit. Care Med. 2008, 178, 34-41. [CrossRef] [PubMed]
21. Standiford, T.J.; Arenberg, D.A.; Danforth, J.M.; Kunkel, S.L.; VanOtteren, G.M.; Strieter, R.M. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: A cellular and molecular analysis. Infect. Immun. 1994, 62, 119-125. [PubMed]
22. Soell, M.; Diab, M.; Haan-Archipoff, G.; Beretz, A.; Herbelin, C.; Poutrel, B.; Klein, J.P. Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (kb) cells, endothelial cells, and monocytes and induce release of cytokines. Infect. Immun. 1995, 63, 1380-1386. [PubMed]
23. Yao, L.; Lowy, F.D.; Berman, J.W. Interleukin-8 gene expression in Staphylococcus aureus-infected endothelial cells. Infect. Immun. 1996, 64, 3407-3409. [PubMed]
24. Abram, C.L.; Lowell, C.A. The ins and outs of leukocyte integrin signaling. Annu. Rev. Immunol. 2009, 27, 339-362. [CrossRef] [PubMed]
25. Akira, S.; Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4, 499-511. [CrossRef] [PubMed]
26. Kanneganti, T.D.; Lamkanfi, M.; Nunez, G. Intracellular nod-like receptors in host defense and disease. Immunity 2007, 27, 549-559. [CrossRef] [PubMed]
27. Liu, C.; Xu, Z.; Gupta, D.; Dziarski, R. Peptidoglycan recognition proteins: A novel family of four human innate immunity pattern recognition molecules. J. Biol. Chem. 2001, 276, 34686-34694. [CrossRef] [PubMed]
28. McKenzie, S.E.; Schreiber, A.D. Fc gamma receptors in phagocytes. Curr. Opin. Hematol. 1998, 5, 16-21. [CrossRef] [PubMed]
29. Sengelov, H. Complement receptors in neutrophils. Crit. Rev. Immunol. 1995, 15, 107-131. [CrossRef] [PubMed]
30. Nunes, P.; Demaurex, N.; Dinauer, M.C. Regulation of the nadph oxidase and associated ion fluxes during phagocytosis. Traffic 2013, 14, 1118-1131. [CrossRef] [PubMed]
31. DeLeo, F.R.; Allen, L.A.; Apicella, M.; Nauseef, W.M. Nadph oxidase activation and assembly during phagocytosis. J. Immunol. 1999, 163, 6732-6740. [PubMed]
32. Nauseef, W.M.; Borregaard, N. Neutrophils at work. Nat. Immunol. 2014, 15, 602-611. [CrossRef] [PubMed]
33. Nauseef, W.M. Detection of superoxide anion and hydrogen peroxide production by cellular nadph oxidases. Biochim. Biophys. Acta 2014, 1840, 757-767. [CrossRef] [PubMed]
34. Winterbourn, C.C.; Kettle, A.J. Redox reactions and microbial killing in the neutrophil phagosome. Antioxid. Redox Signal. 2013, 18, 642-660. [CrossRef] [PubMed]
35. Faurschou, M.; Borregaard, N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003, 5, 1317-1327. [CrossRef] [PubMed]
36. Borregaard, N.; Sorensen, O.E.; Theilgaard-Monch, K. Neutrophil granules: A library of innate immunity proteins. Trends Immunol. 2007, 28, 340-345. [CrossRef] [PubMed]
37. Hirsch, J.G.; Cohn, Z.A. Degranulation of polymorphonuclear leucocytes following phagocytosis of microorganisms. J. Exp. Med. 1960, 112, 1005-1014. [CrossRef] [PubMed]
38. Lominadze, G.; Powell, D.W.; Luerman, G.C.; Link, A.J.; Ward, R.A.; McLeish, K.R. Proteomic analysis of human neutrophil granules. Mol. Cell. Proteom. 2005, 4, 1503-1521. [CrossRef] [PubMed]
39. Kobayashi, S.D.; DeLeo, F.R. Role of neutrophils in innate immunity: A systems biology-level approach. Wiley Interdiscip. Rev. Syst. Biol. Med. 2009, 1, 309-333. [CrossRef] [PubMed]
40. Buckley, C.D.; Gilroy, D.W.; Serhan, C.N. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 2014, 40, 315-327. [CrossRef] [PubMed]
41. DeLeo, F.R.; Diep, B.A.; Otto, M. Host defense and pathogenesis in Staphylococcus aureus infections. Infect. Dis. Clin. N. Am. 2009, 23, 17-34. [CrossRef] [PubMed]
42. Rigby, K.M.; DeLeo, F.R. Neutrophils in innate host defense against Staphylococcus aureus infections. Semin. Immunopathol. 2012, 34, 237-259. [CrossRef] [PubMed]
43. De Haas, C.J.; Veldkamp, K.E.; Peschel, A.; Weerkamp, F.; Van Wamel, W.J.; Heezius, E.C.; Poppelier, M.J.; Van Kessel, K.P.; van Strijp, J.A. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 2004, 199, 687-695. [CrossRef] [PubMed]
44. Postma, B.; Poppelier, M.J.; van Galen, J.C.; Prossnitz, E.R.; van Strijp, J.A.; de Haas, C.J.; van Kessel, K.P. Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the c5a and formylated peptide receptor. J. Immunol. 2004, 172, 6994-7001. [CrossRef] [PubMed]
45. Van Wamel, W.J.; Rooijakkers, S.H.; Ruyken, M.; van Kessel, K.P.; van Strijp, J.A. The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages. J. Bacteriol. 2006, 188, 1310-1315. [CrossRef] [PubMed]
46. Jin, T.; Bokarewa, M.; Foster, T.; Mitchell, J.; Higgins, J.; Tarkowski, A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 2004, 172, 1169-1176. [CrossRef] [PubMed]
47. Xu, S.X.; Gilmore, K.J.; Szabo, P.A.; Zeppa, J.J.; Baroja, M.L.; Haeryfar, S.M.; McCormick, J.K. Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo. Infect. Immun. 2014, 82, 3588-3598. [CrossRef] [PubMed]
48. Lei, L.; Altstaedt, J.; von der Ohe, M.; Proft, T.; Gross, U.; Rink, L. Induction of interleukin-8 in human neutrophils after mhc class ii cross-linking with superantigens. J. Leukoc. Biol. 2001, 70, 80-86. [PubMed]
49. Hopkins, P.A.; Fraser, J.D.; Pridmore, A.C.; Russell, H.H.; Read, R.C.; Sriskandan, S. Superantigen recognition by hla class ii on monocytes up-regulates toll-like receptor 4 and enhances proinflammatory responses to endotoxin. Blood 2005, 105, 3655-3662. [CrossRef] [PubMed]
50. Stapels, D.A.; Ramyar, K.X.; Bischoff, M.; von Kockritz-Blickwede, M.; Milder, F.J.; Ruyken, M.; Eisenbeis, J.; McWhorter, W.J.; Herrmann, M.; van Kessel, K.P. et al. Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors. Proc. Natl. Acad. Sci. USA 2014, 111, 13187-13192. [CrossRef] [PubMed]
51. Stapels, D.A.; Kuipers, A.; von Kockritz-Blickwede, M.; Ruyken, M.; Tromp, A.T.; Horsburgh, M.J.; de Haas, C.J.; van Strijp, J.A.; van Kessel, K.P.; Rooijakkers, S.H. Staphylococcus aureus protects its immune-evasion proteins against degradation by neutrophil serine proteases. Cell. Microbiol. 2015. [CrossRef] [PubMed]
52. Bestebroer, J.; Aerts, P.C.; Rooijakkers, S.H.; Pandey, M.K.; Kohl, J.; van Strijp, J.A.; de Haas, C.J. Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell. Microbiol. 2010, 12, 1506-1516. [CrossRef] [PubMed]
53. Langley, R.; Wines, B.; Willoughby, N.; Basu, I.; Proft, T.; Fraser, J.D. The staphylococcal superantigen-like protein 7 binds iga and complement c5 and inhibits iga-fc alpha ri binding and serum killing of bacteria. J. Immunol. 2005, 174, 2926-2933. [CrossRef] [PubMed]
54. Bestebroer, J.; Poppelier, M.J.; Ulfman, L.H.; Lenting, P.J.; Denis, C.V.; van Kessel, K.P.; van Strijp, J.A.; de Haas, C.J. Staphylococcal superantigen-like 5 binds psgl-1 and inhibits p-selectin-mediated neutrophil rolling. Blood 2007, 109, 2936-2943. [CrossRef] [PubMed]
55. Bestebroer, J.; van Kessel, K.P.; Azouagh, H.; Walenkamp, A.M.; Boer, I.G.; Romijn, R.A.; van Strijp, J.A.; de Haas, C.J. Staphylococcal ssl5 inhibits leukocyte activation by chemokines and anaphylatoxins. Blood 2009, 113, 328-337. [CrossRef] [PubMed]
56. Rooijakkers, S.H.; Ruyken, M.; Roos, A.; Daha, M.R.; Presanis, J.S.; Sim, R.B.; van Wamel, W.J.; van Kessel, K.P.; van Strijp, J.A. Immune evasion by a staphylococcal complement inhibitor that acts on c3 convertases. Nat. Immunol. 2005, 6, 920-927. [CrossRef] [PubMed]
57. Jongerius, I.; Kohl, J.; Pandey, M.K.; Ruyken, M.; van Kessel, K.P.; van Strijp, J.A.; Rooijakkers, S.H. Staphylococcal complement evasion by various convertase-blocking molecules. J. Exp. Med. 2007, 204, 2461-2471. [CrossRef] [PubMed]
58. Rooijakkers, S.H.; Ruyken, M.; van Roon, J.; van Kessel, K.P.; van Strijp, J.A.; van Wamel, W.J. Early expression of scin and chips drives instant immune evasion by staphylococcus aureus. Cell. Microbiol. 2006, 8, 1282-1293. [CrossRef] [PubMed]
59. Ko, Y.P.; Kuipers, A.; Freitag, C.M.; Jongerius, I.; Medina, E.; van Rooijen, W.J.; Spaan, A.N.; van Kessel, K.P.; Hook, M.; Rooijakkers, S.H. Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface. PLoS Pathog. 2013, 9, e1003816. [CrossRef] [PubMed]
60. Laarman, A.J.; Mijnheer, G.; Mootz, J.M.; van Rooijen, W.J.; Ruyken, M.; Malone, C.L.; Heezius, E.C.; Ward, R.; Milligan, G.; van Strijp, J.A. et al. Staphylococcus aureus staphopain a inhibits cxcr2-dependent neutrophil activation and chemotaxis. EMBO J. 2012, 31, 3607-3619. [CrossRef] [PubMed]
61. Dossett, J.H.; Kronvall, G.; Williams, R.C., Quie, P.G. Antiphagocytic effects of staphylococcal protein a. J. Immunol. 1969, 103, 1405-1410. [PubMed]
62. Peterson, P.K.; Verhoef, J.; Sabath, L.D.; Quie, P.G. Effect of protein a on staphylococcal opsonization. Infect. Immun. 1977, 15, 760-764. [PubMed]
63. Zhang, L.; Jacobsson, K.; Vasi, J.; Lindberg, M.; Frykberg, L. A second igg-binding protein in Staphylococcus aureus. Microbiology 1998, 144, 985-991. [CrossRef] [PubMed]
64. Smith, E.J.; Visai, L.; Kerrigan, S.W.; Speziale, P.; Foster, T.J. The sbi protein is a multifunctional immune evasion factor of Staphylococcus aureus. Infect. Immun. 2011, 79, 3801-3809. [CrossRef] [PubMed]
65. Thakker, M.; Park, J.S.; Carey, V.; Lee, J.C. Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect. Immun. 1998, 66, 5183-5189. [PubMed]
66. Nanra, J.S.; Buitrago, S.M.; Crawford, S.; Ng, J.; Fink, P.S.; Hawkins, J.; Scully, I.L.; McNeil, L.K.; Aste-Amezaga, J.M.; Cooper, D. et al. Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Hum. Vaccines Immunother. 2013, 9, 480-487. [CrossRef]
67. Higgins, J.; Loughman, A.; van Kessel, K.P.; van Strijp, J.A.; Foster, T.J. Clumping factor a of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiol. Lett. 2006, 258, 290-296. [CrossRef] [PubMed]
68. Visai, L.; Yanagisawa, N.; Josefsson, E.; Tarkowski, A.; Pezzali, I.; Rooijakkers, S.H.; Foster, T.J.; Speziale, P. Immune evasion by Staphylococcus aureus conferred by iron-regulated surface determinant protein isdh. Microbiology 2009, 155, 667-679. [CrossRef] [PubMed]
69. Rogers, D.E. Studies on bacteriemia. I. Mechanisms relating to the persistence of bacteriemia in rabbits following the intravenous injection of staphylococci. J. Exp. Med. 1956, 103, 713-742. [CrossRef] [PubMed]
70. Gregory, S.H.; Sagnimeni, A.J.; Wing, E.J. Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils. J. Immunol. 1996, 157, 2514-2520. [PubMed]
71. Voyich, J.M.; Braughton, K.R.; Sturdevant, D.E.; Whitney, A.R.; Said-Salim, B.; Porcella, S.F.; Long, R.D.; Dorward, D.W.; Gardner, D.J.; Kreiswirth, B.N. et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J. Immunol. 2005, 175, 3907-3919. [CrossRef] [PubMed]
72. Lu, T.; Porter, A.R.; Kennedy, A.D.; Kobayashi, S.D.; DeLeo, F.R. Phagocytosis and killing of Staphylococcus aureus by human neutrophils. J. Innate. Immun. 2014, 6, 639-649. [CrossRef] [PubMed]
73. Rogers, D.E.; Tompsett, R. The survival of staphylococci within human leukocytes. J. Exp. Med. 1952, 95, 209-230. [CrossRef] [PubMed]
74. Rogers, D.E. Experimental observations on staphylococcal disease. Postep. Mirobiologii. 1966, 5, 279-296.
75. Gresham, H.D.; Lowrance, J.H.; Caver, T.E.; Wilson, B.S.; Cheung, A.L.; Lindberg, F.P. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 2000, 164, 3713-3722. [CrossRef] [PubMed]
76. Kapral, F.A.; Shayegani, M.G. Intracellular survival of staphylococci. J. Exp. Med. 1959, 110, 123-138. [CrossRef] [PubMed]
77. Kobayashi, S.D.; Braughton, K.R.; Palazzolo-Ballance, A.M.; Kennedy, A.D.; Sampaio, E.; Kristosturyan, E.; Whitney, A.R.; Sturdevant, D.E.; Dorward, D.W.; Holland, S.M. et al. Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J. Innate. Immun. 2010, 2, 560-575. [CrossRef] [PubMed]
78. Karavolos, M.H.; Horsburgh, M.J.; Ingham, E.; Foster, S.J. Role and regulation of the superoxide dismutases of Staphylococcus aureus. Microbiology 2003, 149, 2749-2758. [CrossRef] [PubMed]
79. Cosgrove, K.; Coutts, G.; Jonsson, I.M.; Tarkowski, A.; Kokai-Kun, J.F.; Mond, J.J.; Foster, S.J. Catalase (kata) and alkyl hydroperoxide reductase (ahpc) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus. J. Bacteriol. 2007, 189, 1025-1035. [CrossRef] [PubMed]
80. Liu, G.Y.; Essex, A.; Buchanan, J.T.; Datta, V.; Hoffman, H.M.; Bastian, J.F.; Fierer, J.; Nizet, V. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 2005, 202, 209-215. [CrossRef] [PubMed]
81. Cassat, J.E.; Skaar, E.P. Iron in infection and immunity. Cell Host Microbe 2013, 13, 509-519. [CrossRef] [PubMed]
82. Holland, S.M. Chronic granulomatous disease. Hematol. Oncol. Clin. N. Am. 2013, 27, 89-99. [CrossRef] [PubMed]
83. Pincus, S.H.; Klebanoff, S.J. Quantitative leukocyte iodination. N. Engl. J. Med. 1971, 284, 744-750. [CrossRef] [PubMed]
84. Klebanoff, S.J.; Kettle, A.J.; Rosen, H.; Winterbourn, C.C.; Nauseef, W.M. Myeloperoxidase: A front-line defender against phagocytosed microorganisms. J. Leukoc. Biol. 2013, 93, 185-198. [CrossRef] [PubMed]
85. Chapman, A.L.; Hampton, M.B.; Senthilmohan, R.; Winterbourn, C.C.; Kettle, A.J. Chlorination of bacterial and neutrophil proteins during phagocytosis and killing of Staphylococcus aureus. J. Biol. Chem. 2002, 277, 9757-9762. [CrossRef] [PubMed]
86. Peschel, A.; Otto, M.; Jack, R.W.; Kalbacher, H.; Jung, G.; Gotz, F. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 1999, 274, 8405-8410. [CrossRef] [PubMed]
87. Collins, L.V.; Kristian, S.A.; Weidenmaier, C.; Faigle, M.; Van Kessel, K.P.; Van Strijp, J.A.; Gotz, F.; Neumeister, B.; Peschel, A. Staphylococcus aureus strains lacking d-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J. Infect. Dis. 2002, 186, 214-219. [CrossRef] [PubMed]
88. Peschel, A.; Jack, R.W.; Otto, M.; Collins, L.V.; Staubitz, P.; Nicholson, G.; Kalbacher, H.; Nieuwenhuizen, W.F.; Jung, G.; Tarkowski, A. et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor mprf is based on modification of membrane lipids with l-lysine. J. Exp. Med. 2001, 193, 1067-1076. [CrossRef] [PubMed]
89. Bera, A.; Herbert, S.; Jakob, A.; Vollmer, W.; Gotz, F. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan o-acetyltransferase oata is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol. Microbiol. 2005, 55, 778-787. [CrossRef] [PubMed]
90. Wang, R.; Braughton, K.R.; Kretschmer, D.; Bach, T.H.; Queck, S.Y.; Li, M.; Kennedy, A.D.; Dorward, D.W.; Klebanoff, S.J.; Peschel, A. et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated mrsa. Nat. Med. 2007, 13, 1510-1514. [CrossRef] [PubMed]
91. Gladstone, G.P.; Van Heyningen, W.E. Staphylococcal leucocidins. Br. J. Exp. Pathol. 1957, 38, 123-137. [PubMed]
92. Woodin, A.M. Staphylococcal leukocidin. Ann. N Y Acad. Sci. 1965, 128, 152-164. [CrossRef] [PubMed]
93. Panton, P.N.; Valentine, F.C.O. Staphylococcal toxin. Lancet 1932, 219, 506-508. [CrossRef]
94. Ventura, C.L.; Malachowa, N.; Hammer, C.H.; Nardone, G.A.; Robinson, M.A.; Kobayashi, S.D.; DeLeo, F.R. Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS ONE 2010, 5, e11634. [CrossRef] [PubMed]
95. Dumont, A.L.; Nygaard, T.K.; Watkins, R.L.; Smith, A.; Kozhaya, L.; Kreiswirth, B.N.; Shopsin, B.; Unutmaz, D.; Voyich, J.M.; Torres, V.J. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol. Microbiol. 2011, 79, 814-825. [CrossRef] [PubMed]
96. Malachowa, N.; Whitney, A.R.; Kobayashi, S.D.; Sturdevant, D.E.; Kennedy, A.D.; Braughton, K.R.; Shabb, D.W.; Diep, B.A.; Chambers, H.F.; Otto, M. et al. Global changes in Staphylococcus aureus gene expression in human blood. PLoS ONE 2011, 6, e18617. [CrossRef] [PubMed]
97. Surewaard, B.G.; de Haas, C.J.; Vervoort, F.; Rigby, K.M.; DeLeo, F.R.; Otto, M.; van Strijp, J.A.; Nijland, R. Staphylococcal alpha-phenol soluble modulins contribute to neutrophil lysis after phagocytosis. Cell. Microbiol. 2013, 15, 1427-1437. [CrossRef] [PubMed]
98. Greenlee-Wacker, M.C.; Rigby, K.M.; Kobayashi, S.D.; Porter, A.R.; DeLeo, F.R.; Nauseef, W.M. Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis. J. Immunol. 2014, 192, 4709-4717. [CrossRef] [PubMed]